BCAS3 antibody

Cat.#: 108381

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    BCAS3 antibody
  • Documents
  • Description
    BCAS3 Rabbit Polyclonal antibody. Positive WB detected in HeLa cells, MCF7 cells. Observed molecular weight by Western-blot: 74kd
  • Tested applications
    ELISA, WB
  • Species reactivity
    Human,Mouse,Rat; other species not tested.
  • Alternative names
    BCAS3 antibody; DKFZp686O1527 antibody; FLJ20128 antibody; GAOB1 antibody; MAAB antibody; Protein Maab1 antibody; Rudhira antibody
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained by immunization of BCAS3 recombinant protein (Accession Number: BC001250). Purification method: Antigen affinity purified.
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: 1:200-1:1000

  • Validations

    HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:108381(BCAS3 antibody) at dilution of 1:400

    HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:108381(BCAS3 antibody) at dilution of 1:400

  • Background
    Rudhira/BCAS3 (Breast Cancer Amplified Sequence 3) is a conserved protein expressed in the embryonic vasculature and malignant tumors. Rudhira is a predicted WD40 domain protein. During mouse development Rudhira is expressed in erythropoietic and angiogenic precursors but not in their differentiated progeny. This transient expression of Rudhira is also seen in normal adult angiogenesis. BCAS3, the human ortholog of Rudhira is 98% identical and the gene maps to a breakpoint of hematological neoplasms on chromosome 17q23.1. BCAS3 is also expressed in vascular development in embryoid bodies in vitro and was originally identified as a gene over-expressed in breast cancers. It is reported to be a target of metastasis associated protein-1 (MTA-1). Further BCAS3 expression is also upregulated in grade III and IV glioblastomas where it is misexpressed in the tumor cells.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"